Glucotrack, Inc. Reports Shareholder Vote
Ticker: GCTK · Form: 8-K · Filed: Sep 26, 2024 · CIK: 1506983
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Glucotrack held a shareholder vote on 9/24, details to follow.
AI Summary
Glucotrack, Inc. filed an 8-K on September 26, 2024, reporting on a matter submitted to a vote of its security holders on September 24, 2024. The filing does not specify the outcome or details of the vote.
Why It Matters
Shareholder votes can impact corporate governance, strategic decisions, and the company's direction.
Risk Assessment
Risk Level: low — This filing is procedural and reports on a shareholder vote without immediate financial implications or significant new information.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- September 24, 2024 (date) — Date of earliest event reported
- September 26, 2024 (date) — Filing date
FAQ
What was the specific matter submitted to a vote of Glucotrack, Inc.'s security holders on September 24, 2024?
The filing does not specify the exact matter that was submitted for a vote.
What was the outcome of the shareholder vote on September 24, 2024?
The filing does not disclose the results or outcome of the shareholder vote.
When did Glucotrack, Inc. file this 8-K report?
Glucotrack, Inc. filed this 8-K report on September 26, 2024.
What is the principal executive office address for Glucotrack, Inc.?
The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.
What is Glucotrack, Inc.'s IRS Employer Identification Number?
Glucotrack, Inc.'s IRS Employer Identification Number is 98-0668934.
Filing Stats: 670 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2024-09-26 17:14:58
Key Financial Figures
- $0.001 — f the Company's common stock, par value $0.001 per share (the "common stock") issued a
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-24-038358.txt ( ) — 210KB
- gctk-20240924.xsd (EX-101.SCH) — 3KB
- gctk-20240924_lab.xml (EX-101.LAB) — 33KB
- gctk-20240924_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 26, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer